Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of clarithromycin 500
mg tablets (Ranbaxy Laboratories Limited) with that of BIAXIN® 500 mg tablets in healthy,
adult subjects under non-fasting conditions.